DOI 10.1016/j.jconrel.2025.114394
Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration.
Аннотация
Neovascular age-related macular degeneration (nAMD), characterized by choroidal neovascularization (CNV), is a major cause of blindness worldwide. Current anti-vascular endothelial growth factor (VEGF) therapy remains unsatisfactory, as this single-target treatment only alleviates the symptoms without addressing the underlying etiology. Emerging research indicates that inflammation and oxidative stress are closely related to early nAMD, where the retinal pigment epithelium (RPE) is initially impaired, leading to pathological angiogenesis. Herein, biomimetic nanoparticles (termed SHP/Cur@MNPs) are prepared by co-encapsulating SHP099, an anti-inflammatory and anti-angiogenic agent, and curcumin, an antioxidant, into poly (lactic-co-glycolic acid) (PLGA) coated with macrophage membrane. Taking advantage of the macrophage-inherited property, SHP/Cur@MNPs effectively targeted the inflamed foci, specifically the vascular endothelium. Using a laser-induced CNV mouse model, SHP/Cur@MNPs markedly inhibited neovascularization, reduced inflammation and oxidative stress, and improved retinal function. Furthermore, bioinformatics analysis explored the mechanism of the Hippo signaling pathway in the treatment of SHP/Cur@MNPs against nAMD. Collectively, our study describes a strategy using biomimetic nanoparticles to achieve the synergistic effect by targeting major risk factors associated with nAMD, which might be a novel approach for the safe and effective treatment of nAMD.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.